Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/150452
Registo completo
Campo DCValorIdioma
dc.creatorSalehi, B
dc.creatorQuispe, C
dc.creatorSharifi-Rad, J
dc.creatorMartins, N
dc.creatorNigam, M
dc.creatorMishra, AP
dc.creatorKonovalov, DA
dc.creatorOrobinskaya, V
dc.creatorAbu-Reidah, IM
dc.creatorZam, W
dc.creatorSharopov, F
dc.creatorVenneri, T
dc.creatorCapasso, R
dc.creatorKukula-Koch, W
dc.creatorWawruszak, A
dc.creatorKoch, W
dc.date.accessioned2023-06-27T13:24:34Z-
dc.date.available2023-06-27T13:24:34Z-
dc.date.issued2021
dc.identifier.issn1663-9812
dc.identifier.urihttps://hdl.handle.net/10216/150452-
dc.description.abstractPhytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.
dc.description.sponsorshipNCM acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/ 28076/2017).
dc.language.isoeng
dc.publisherFrontiers Media
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FPSI-GER%2F28076%2F2017/PT
dc.relation.ispartofFrontiers in Pharmacology, vol.11:599959
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titlePhytosterols: From Preclinical Evidence to Potential Clinical Applications
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3389/fphar.2020.599959
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fphar.2020.599959/full
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.3389-fphar.2020.599959.pdf1.55 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons